The IPO is now effective, meaning pricing and trading could occur within 1-2 days. Traders should watch for the final IPO price and first-day trading performance. The $6-$8 range implies a pre-money valuation of roughly $15-$20M on a $28M market cap, which could attract retail interest in the psychedelic sector. Monitor for the pricing announcement and any lock-up agreement details.
Price Chart
Executive Summary
The SEC declared Optimi Health Corp.'s F-1 registration statement effective on August 25, 2026, clearing the way for its U.S. IPO of 2.5 million common shares at an expected price range of $6.00-$8.00 per share. This is a milestone event for the Canadian psychedelic pharmaceutical manufacturer, as Nasdaq listing and the IPO pricing are now the next steps. The cross-filing context confirms this is an IPO effectiveness, not a shelf registration, and the actuarial calibration flags this combo as an amplifier, supporting a higher impact score.
Key Facts
- SEC declared Optimi Health Corp.'s F-1 registration statement effective on August 25, 2026 (File No. 333-298364).
- The IPO involves 2.5 million common shares at an expected price range of $6.00-$8.00 per share, with an over-allotment option of 375,000 shares.
- The maximum aggregate offering price is $38.985 million.
- Nasdaq listing is a condition to closing the IPO.
- The cross-filing actuarial verdict flags the IPO-context + shelf-context combination as an AMPLIFIER (PMI=7.04, q=0.000, n=321), supporting an elevated impact score.
Financial Impact
IPO of up to 2.5M shares at $6-$8/share, raising up to ~$20M (excluding over-allotment). Total maximum aggregate offering price of $38.985M.
Risk Factors
- IPO pricing may come in below the expected range if market conditions are unfavorable.
- Nasdaq listing is a condition to closing; any delay or failure would be a significant negative.
- The company is a pre-revenue or early-stage biotech with a $28M market cap, making it highly volatile post-IPO.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002760 |
| Document: 9999999995-26-002760-index.html | 9999999995-26-002760 |
| Document: 9999999995-26-002760.txt | 9999999995-26-002760 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.36 | awaiting T+5 | — | $3.12 (−7.14%) |
Oct 20, 2026 6d ago | 6-K | $3.36 | awaiting T+5 | — | $3.12 (−7.14%) |
Oct 7, 2026 19d ago | 6-K | $4.04 $3.17 | ▼ −21.66% | ▼ −20.68% | $3.12 (−22.77%) |
Oct 5, 2026 21d ago | SC 13G/A | $4.13 $3.50 | ▼ −15.25% | ▼ −15.12% | $3.12 (−24.46%) |
Sep 29, 2026 27d ago | 6-K | $4.78 $4.13 | ▼ −13.60% | ▼ −15.55% | $3.12 (−34.73%) |
Sep 23, 2026 4w ago | 6-K | $4.96 $4.71 | ▼ −5.04% | ▼ −4.37% | $3.12 (−37.10%) |
Sep 22, 2026 4w ago | 6-K | $4.96 $4.78 | ▼ −3.63% | ▼ −2.44% | $3.12 (−37.10%) |
Sep 16, 2026 5w ago | 6-K | $4.90 $4.96 | ▲ +1.22% | ▼ −0.60% | $3.12 (−36.33%) |
Sep 10, 2026 6w ago | 6-K | $4.50 $4.96 | ▲ +10.22% | ▲ +10.72% | $3.12 (−30.67%) |
Aug 26, 2026 8w ago | 6-K | $4.89 $4.70 | ▲ +3.89% | ▲ +4.15% | $3.12 (+36.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers